Literature DB >> 17010992

Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates.

Chunjuan Huang1, Han Cheng, Shufeng Hao, Hui Zhou, Xujia Zhang, Jianen Gao, Qi-Hong Sun, Hongyu Hu, Chih-Chen Wang.   

Abstract

alpha-Synuclein (AS) is a main component of Lewy bodies in midbrain dopamine neurons pathologically characteristic of Parkinson's disease. We show that heat shock protein (Hsp) 70 inhibits AS fibril formation via preventing the formation of prefibrillar AS (PreAS), binding with PreAS to impede nuclei formation, and binding with nuclei to retard fibril elongation. Also, Hsp70 suppresses the PreAS-induced permeabilization of vesicular membrane through interactions with PreAS. The substrate-binding domain alone is sufficient for Hsp70 to inhibit AS fibril formation. The binding of Hsp70 with PreAS only requires the substrate-binding subdomain, and the binding with AS nuclei requires the C-terminal lid subdomain as well. The results may form the molecular basis for elucidating the mechanism of AS fibril formation and the crucial roles of chaperones in protecting proteins from toxic conversion in many conformational diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010992     DOI: 10.1016/j.jmb.2006.08.062

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  41 in total

1.  Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.

Authors:  Samantha Pemberton; Karine Madiona; Laura Pieri; Mehdi Kabani; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

Review 4.  Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

Authors:  Herman van der Putten; Gregor P Lotz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

5.  DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.

Authors:  Sara Batelli; Diego Albani; Raffaela Rametta; Letizia Polito; Francesca Prato; Marzia Pesaresi; Alessandro Negro; Gianluigi Forloni
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

6.  Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation.

Authors:  Han Cheng; Lei Wang; Chih-chen Wang
Journal:  Cell Stress Chaperones       Date:  2009-12-04       Impact factor: 3.667

7.  Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.

Authors:  Virginie Redeker; Samantha Pemberton; Willy Bienvenut; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

8.  Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.

Authors:  Guiping Du; Xiang Liu; Xinping Chen; Mei Song; Yan Yan; Renjie Jiao; Chih-Chen Wang
Journal:  Mol Biol Cell       Date:  2010-05-05       Impact factor: 4.138

9.  Heat shock protein 90 in neurodegenerative diseases.

Authors:  Wenjie Luo; Weilin Sun; Tony Taldone; Anna Rodina; Gabriela Chiosis
Journal:  Mol Neurodegener       Date:  2010-06-03       Impact factor: 14.195

10.  The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.

Authors:  Timothy S Jarvela; Hoa A Lam; Michael Helwig; Nikolai Lorenzen; Daniel E Otzen; Pamela J McLean; Nigel T Maidment; Iris Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.